The latest edition of the Lung-MAP newsletter is now available for our clinical trial sites.

Get the news on our major expansion, and what it means for your hospital or clinic here.

You can also get more information about Lung-MAP, a lung cancer precision medicine trial, at the trial website.

Lung-MAP tests new treatments for advanced non-small cell lung cancers, and is supported by a unique public-private partnership that includes the National Cancer Institute, the Foundation for the National Institutes of Health, Friends of Cancer Research, and the SWOG Cancer Research Network.